The Liposomal Delivery Advantage To solve the problem of absorption, we utilize liposomal delivery
Published clinical research has characterised the compound in controlled trials: a Phase 2 obesity trial reported dose-dependent body-weight change in the study population (Jastreboff et al., 2023), and a separate Phase 2 trial investigated the GIP/GLP-1/glucagon agonist in people with type 2 diabetes (Rosenstock et al., 2023)
Rather than chasing trends, we formulate products that support the skins natural repair mechanisms and overall cellular health
PD-5 treatment, on the other hand, is a natural medicine that is recommended for patients where excessive rigidity gets worse while walking
All this flavourful experience comes at the cost of ZERO guilt as the formula has ZERO sugar carbs and calories.
The two peptides are also not the same kind of molecule